Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Endocrine Cancer
Radioiodine Provides No Benefit After Thyroidectomy in Low-Risk Thyroid Cancer
Radioiodine after thyroidectomy did not improve outcomes in patients with low-risk thyroid cancer.
3MT Gene Signature May Predict Poor Outcomes in Neuroblastoma
Elevated urinary 3MT levels were tied to worse event-free and overall survival.
Survey Reveals ‘Striking’ Barriers to Accessing High-Priority Cancer Drugs
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
- Loading...
Loading...
Loading... 
Loading...